• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

MED- Good luck


<



















Good luck to all. Wondering if the NBU is next?

Steve says we’re safe for now....but guaranteed nothing. So don’t spend much this Christmas. My prediction(guessing) is either January or March 50% reduction. Every territory can easily survive with only one rep. Time to trim the fat around here
 
































When is yours? Did you go to one virtual rep and one rep in the field as partners?

Not yet. Having 1 virtual rep and one office based rep is about the worst business decision a pharmaceutical company could make! We need 1 office base rep per territory and maybe 2 or 3 virtual reps per state just for key providers. That would mean about a 70% cut which will never happen.
 




Similar threads

Replies
156
Views
28K
Takeda
anonymous
Replies
1
Views
1K
Takeda
anonymous
Replies
7
Views
2K
Takeda
Anonymous